Ichor Holdings, Ltd. $ICHR Shares Bought by Royce & Associates LP
Royce & Associates LP increased its Ichor Holdings (NASDAQ:ICHR) stake by 48.5% in Q4 to 1,449,082 shares, worth $26.71M, after buying 473,440 shares, according to SEC filings cited by HoldingsChannel. Other institutions also added shares. CEO Philip Ryan Sr. Barros sold 21,000 shares at $46.63. Analysts raised price targets; consensus average is $64.57.
How this was made
The 30-second read
Why it matters
Institutional accumulation (Royce + other funds) and multiple analyst target increases after an earnings beat suggest improving expectations, but insider selling and negative net margin/ROE temper conviction.
Market read
This is primarily a positioning/expectations update for ICHR: institutional buying plus upward target revisions following a recent earnings beat and Q2 EPS guidance.
What to watch
The article lacks order-book/backlog or guidance detail beyond EPS range; without demand visibility, the stock could still re-rate on sentiment rather than fundamentals.
Background
Ichor supplies gas delivery systems, vacuum pumps, and abatement solutions used in semiconductor fabrication tools; the stock recently reported May 4 quarterly results and issued Q2 2026 EPS guidance.
Ticker impact
Royce & Associates raised its Ichor stake 48.5% in Q4, adding 473,440 shares, while multiple brokerages lifted ICHR targets after recent results.
Near-term bias to upside/volatility as positioning improves and street targets cluster around the mid-$60s to $80 range.
The only company-specific catalysts cited are (1) Q4 institutional buying, (2) insider selling (a mild offset), and (3) analyst target increases after an earnings beat with positive revenue growth and Q2 EPS guidance.
Market effects
As a semiconductor process-systems supplier, ICHR strength/expectations can modestly support sentiment toward equipment subsystems tied to wafer-fab capex cycles.
No direct regional catalyst beyond ICHR’s global customer base; impact is primarily US-listed sentiment.
Semiconductor supply-chain read-through is global, but the article provides no new international contract/regulatory trigger.
Counterpoint
Insiders sold meaningfully over the last 90 days (40,260 shares), which can signal caution despite institutional buying and target hikes.
Key entities
- companyIchor Holdings, Ltd.
NASDAQ-listed semiconductor subsystems supplier; subject of institutional buying, insider sales, and recent earnings/guidance.
- institutional_investorRoyce & Associates LP
Raised its ICHR position by 48.5% in Q4 per the article.
- brokerage_firmsOppenheimer / Needham / Stifel Nicolaus / TD Cowen
Raised ICHR price targets and reiterated Buy/positive stances in May research notes.
